Menu
Home
People
Places
Arts
History
Plants & Animals
Science
Life & Culture
Technology
Reference.org
Abemaciclib
open-in-new
<p>Abemaciclib, sold under the brand name Verzenio among others, is a <a href="/facts/Medication/h9mhwWP2">medication</a> for the treatment of advanced or metastatic <a href="/facts/Breast_cancer/6hME580v">breast cancers</a>. It was <a href="/facts/Drug_development/k34jgV4B">developed</a> by <a href="/facts/Eli_Lilly_and_Company/e5Pw7RmR">Eli Lilly</a> and it acts as a <a href="/facts/CDK_inhibitor/ajCus0aA">CDK inhibitor</a> selective for <a href="/facts/CDK4/S2RoVFbk">CDK4</a> and <a href="/facts/CDK6/Ksc3VAvY">CDK6</a>. </p><p>It was designated as a <a href="/facts/Breakthrough_therapy/VYNK0Ve6">breakthrough therapy</a> for breast cancer by the US <a href="/facts/Food_and_Drug_Administration/rCEnh9WB">Food and Drug Administration</a> (FDA) in October 2015. </p><p>In September 2017, it was approved for use in the United States by the FDA for the treatment of certain breast cancers. </p>